Van Thinh To

Van Thinh To


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 May 2024 in RSC Advances
Verified
Journal Article
Open access
PDF file
TPTieu-Long Phan
Tieu-Long Phan
TTThe-Chuong Trinh
The-Chuong Trinh
VTVan Thinh To
Van Thinh To
APAn Thanh Pham
An Thanh Pham
CNChung Nguyen
Chung Nguyen
NTNgoc-Tuyen Truong
Ngoc-Tuyen Truong
HIV-1 (human immunodeficiency virus-1) has been causing severe pandemics by attacking the immune system of its host. Left untreated, it can lead to AIDS (acquired immunodeficiency syndrome), where death is inevitable due to opportunistic diseases. Therefore, discovering new antiviral drugs against HIV-1 is crucial. This study aimed to explore a novel machine learning approach to classify compounds that inhibit HIV-1 integrase and screen the dataset of repurposing compounds. The present study had two main stages: selecting the best type of fingerprint or molecular descriptor using the Wilcoxon signed-rank test and building a computational model based on machine learning. In the first stage, we calculated 16 different types of fingerprint or molecular descriptors from the dataset and used each of them as input features for 10 machine-learning models, which were evaluated through cross-validation. Then, a meta-analysis was performed with the Wilcoxon signed-rank test to select the optimal fingerprint or molecular descriptor types. In the second stage, we constructed a model based on the optimal fingerprint or molecular descriptor type. This data followed the machine learning procedure, including data preprocessing, outlier handling, normalization, feature selection, model selection, external validation, and model optimization. In the end, an XGBoost model and RDK7 fingerprint were identified as the most suitable. The model achieved promising results, with an average precision of 0.928 ± 0.027 and an F1-score of 0.848 ± 0.041 in cross-validation. The model achieved an average precision of 0.921 and an F1-score of 0.889 in external validation. Molecular docking was performed and validated by redocking for docking power and retrospective control for screening power, with the AUC metrics being 0.876 and the threshold being identified at −9.71 kcal mol−1. Finally, 44 compounds from DrugBank repurposing data were selected from the QSAR model, then three candidates were identified as potential compounds from molecular docking, and PSI-697 was detected as the most promising molecule, with in vitro experiment being not performed (docking score: −17.14 kcal mol−1, HIV integrase inhibitory probability: 69.81%)

6 November 2025 in Digital Discovery
Verified
Journal Article
Open access
PDF file
CNChung Nguyen
Chung Nguyen
VTVan Thinh To
Van Thinh To
NTNgoc-Vi Nguyen Tran
Ngoc-Vi Nguyen Tran
TPTieu-Long Phan
Tieu-Long Phan
NTNgoc-Tuyen Truong
Ngoc-Tuyen Truong
Peter F. StadlerPeter F. Stadler
Peter F. Stadler
SynCat is a cross-attention GNN that embeds molecules, detects reagents, and estimates reaction-center embeddings via permutation-invariant pairwise aggregation. It delivers improved reaction-classification performance compared with RXNFP and DRFP.

18 October 2023
Verified
Conference Paper
Closed access
TTThe-Chuong Trinh
The-Chuong Trinh
TPTieu-Long Phan
Tieu-Long Phan
VTVan Thinh To
Van Thinh To
GTGia-Bao Truong
Gia-Bao Truong
APAn Thanh Pham
An Thanh Pham
NTNgoc-Tuyen Truong
Ngoc-Tuyen Truong
Anaplastic lymphoma kinase (ALK), a tyrosine kinase receptor, is identified as a crucial target in the progression of anticancer therapeutics for non-small cell lung cancer. This study has executed a Graph Neural Network (GNN) model and compared it with three machine learning (ML) models based on fingerprints for rapid anticancer bioactivity prediction. ALK inhibitors with IC50 values were extracted from the REAXYS database. Following preprocessing, these inhibitors constituted a dataset of 1664 molecules. Subsequently, GNN and ML models were constructed on a training set. The generalizability of these models was assessed by internal and external validation procedures. The graph neural network model yielded promising results, with an average precision of $0.879\pm 0.041$ and an $F1$ score of $0.804\pm 0.049$ in cross-validation. In external validation, the model achieved an average precision of 0.938 and an $F1$ score of 0.863, surpassing the results of the ML models. Therefore, we can infer that the predictive model developed using the GNN is apt for the problem at hand and can be utilized to predict the biological activity of novel ALK inhibitors.

22 April 2026 in Journal of Cheminformatics
Verified
Journal Article
Open access
PDF file
TPTuyet-Minh Phan
Tuyet-Minh Phan
TPTieu-Long Phan
Tieu-Long Phan
CNChung Nguyen
Chung Nguyen
HLHoang-Son Lai Le
Hoang-Son Lai Le
VTVan Thinh To
Van Thinh To
Peter F. StadlerPeter F. Stadler
Peter F. Stadler
Background: Quantitative structure-activity relationship (QSAR) models are central to computer-aided drug discovery and predictive toxicology, but practical adoption is often impeded by ad-hoc tooling, inconsistent validation protocols, and poor reproducibility. Objective: We introduce , a modular, reproducible workbench that formalizes end-to-end QSAR development while permitting independent use of each component. Methods: composes interchangeable modules for standardization, feature generation, splitting (including scaffold- and cluster-aware splits), preprocessing, outlier handling, scaling, feature selection, model training and tuning, statistical comparison, conformal calibration, and applicability-domain assessment. The pipeline can run end-to-end to produce versioned artifact bundles (serialized models) and analyst-oriented reports suitable for deployment and audit. Results: On representative benchmarks evaluated under Bemis–Murcko scaffold split, attains state-of-the-art descriptor-based performance: the lowest mean RMSE across the regression suite (, , ; mean RMSE $$0.658\pm 0.11$$ 0.658 ± 0.11 ), including a substantial improvement on (RMSE $$0.494$$ 0.494 vs. $$0.731$$ 0.731 for a leading graph method). On quantum mechanical benchmarks, demonstrated superior performance on the single-task dataset and maintained competitive results on the multi-task dataset. For classification, achieves the top ROC–AUC on (91.4%) while remaining competitive across other benchmark (overall classification average $$70.4\pm 11.6$$ 70.4 ± 11.6 ). Crucially, all predictions are accompanied by cross-conformal prediction and explicit applicability-domain flags that identify out-of-distribution entries, enabling calibrated and decision support. Availability: is released on , , and ; all releases embed full provenance (parameters, package versions, checksums) to ensure reproducibility. Scientific contribution: (i) enforces best-practice, group-aware validation together with formal statistical comparisons across models, (ii) integrates calibrated uncertainty quantification (cross-conformal prediction) and applicability-domain diagnostics for interpretable, risk-aware predictions, and (iii) exposes both a composable developer API and a one-click pipeline that generates deployment-ready artifacts and human-readable reports, demonstrated on representative benchmarks.

15 September 2025 in Journal of Computer-Aided Molecular Design
Verified
Journal Article
Closed access
PDF file
TTThe-Chuong Trinh
The-Chuong Trinh
TPTieu-Long Phan
Tieu-Long Phan
VTVan Thinh To
Van Thinh To
APAn Thanh Pham
An Thanh Pham
GTGia-Bao Truong
Gia-Bao Truong
NTNgoc-Tuyen Truong
Ngoc-Tuyen Truong

19 January 2024 in ChemRxiv
Verified
Preprint
Open access
PDF file
XTXuan-Truc Dinh Tran
Xuan-Truc Dinh Tran
TPTieu-Long Phan
Tieu-Long Phan
VTVan Thinh To
Van Thinh To
NTNgoc-Vi Nguyen Tran
Ngoc-Vi Nguyen Tran
NNNhu-Ngoc Song Nguyen
Nhu-Ngoc Song Nguyen
NTNgoc-Tuyen Truong
Ngoc-Tuyen Truong
3D pharmacophore models describe the ligand’s chemical interactions in their bioactive conformation. They offer a simple but sophisticated approach to decipher the chemically encoded ligand information, making them a valuable tool in Drug Design. Our research summarized the key studies for applying 3D pharmacophore models in virtual screening for APJ receptor agonists. Recent advances in clustering algorithms and ensemble methods have enabled classical pharmacophore modeling to evolve into more flexible and knowledge-driven techniques. Butina clustering categorizes molecules based on their structural similarity (indicated by the Tanimoto coefficient) to create a structurally diverse training dataset. The ensemble learning method combines various individual pharmacophore models into a set of pharmacophore models for pharmacophore space optimization in virtual screening. This approach was evaluated on Apelin datasets and afforded good screening performance, as proven by receiver operating characteristic, enrichment factor, Güner-Henry score, and F-measure. Although one of the high-scoring models achieved statistically superior results in each dataset, the ensemble learning method including Voting and Stacking method balanced the shortcomings of each model and passed with close performance measures.